| scholarly article | Q13442814 |
| P50 | author | Sophie D. Fosså | Q17059251 |
| Edit Oláh | Q19514575 | ||
| Jahn M. Nesland | Q73925706 | ||
| P2093 | author name string | Marieke von Lindern | |
| Leendert H J Looijenga | |||
| Ad J M Gillis | |||
| Hans Stoop | |||
| J Wolter Oosterhuis | |||
| Ruud J H L M van Gurp | |||
| Peter Valk | |||
| Wim J Kirkels | |||
| Thamar van Dijk | |||
| Rob F A Weber | |||
| Carlos A de Gouveia Brazao | |||
| Geczy Lajos | |||
| Hubert de Leeuw | |||
| Monique van Oorschot | |||
| P433 | issue | 22 | |
| P304 | page(s) | 7674-7678 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors | |
| P478 | volume | 63 |
| Q37450386 | A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother |
| Q34354383 | A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son |
| Q34768510 | Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors |
| Q84209088 | Bilateral testicular germ cell tumours: a single hospital experience |
| Q35538367 | Biology of childhood germ cell tumours, focussing on the significance of microRNAs |
| Q46678492 | C-kit expression in germinoma: an immunohistochemistry-based study |
| Q34199130 | Cancer stem cells as targets for cancer therapy: selected cancers as examples. |
| Q33347763 | Clinical and genetic aspects of testicular germ cell tumours |
| Q41820355 | Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors. |
| Q98771758 | Cryptorchidism and Testicular Tumor: Comprehensive Analysis of Common Clinical Features and Search of SNVs in the KIT and AR Genes |
| Q64897624 | Detection of KIT mutations in core binding factor acute myeloid leukemia. |
| Q52684455 | EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors. |
| Q26991452 | Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis |
| Q41884323 | Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages |
| Q24614629 | Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors |
| Q41885351 | Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate |
| Q35237447 | Grsf1-induced translation of the SNARE protein Use1 is required for expansion of the erythroid compartment |
| Q61797849 | Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic |
| Q48262511 | IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance |
| Q34665568 | Local signalling environments and human male infertility: what we can learn from mouse models |
| Q36925945 | Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice |
| Q24313261 | Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells |
| Q36169443 | Microinvasive germ cell tumor of the testis |
| Q37209628 | Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis |
| Q37995190 | Molecular genetics of testicular germ cell tumors |
| Q46479059 | Molecular pathology of testicular germ cell tumors: an update |
| Q33200142 | New insights into the pathology and molecular biology of human germ cell tumors. |
| Q35634176 | Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers |
| Q36477671 | Primordial germ cells and gastrointestinal stromal tumors respond distinctly to a cKit overactivating allele |
| Q35859040 | Prognostic value of KIT mutation in gastrointestinal stromal tumors |
| Q38059166 | Recent advances in the biology of germ cell tumors: implications for the diagnosis and treatment |
| Q34452597 | Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults |
| Q41809692 | Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter |
| Q36697196 | Somatic mutations of KIT in familial testicular germ cell tumours |
| Q36236556 | Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study |
| Q37743159 | Synchronous bilateral testis cancer: clinical and oncological management |
| Q37523040 | Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells |
| Q38703547 | Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure? |
| Q38184375 | Testicular cancer: biology and biomarkers |
| Q37853838 | Testicular germ cell tumours: predisposition genes and the male germ cell niche. |
| Q38936739 | The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V. |
| Q38320966 | Translation initiation factor 4E inhibits differentiation of erythroid progenitors. |
| Q46512637 | Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities |
| Q39762519 | Will Testicular Germ Cell Tumors Remain Untargetable? |
| Q28076597 | Zebrafish Germ Cell Tumors |
| Q37598667 | Zebrafish models of germ cell tumor |
| Q53793457 | [Advances in basic research on testicular germ cell tumors : clinical implications]. |
Search more.